
Show Notes
We are delighted to team up with Clinical Laserthermia Systems Americas this week for a groundbreaking episode where we dive into the world of cutting-edge medical technology and shed light on an emerging innovation that promises to revolutionize the management of prostate cancer! CLS is a leading medical device company at the forefront of pioneering precise and effective interventional healthcare solutions. They have developed an innovative CLS thermal therapy system for image-guided focal laser ablation that spares healthy tissue while minimizing the debilitating side effects often associated with traditional treatments. This technology can even be administered by a urologist in an office setting, bringing hope and convenience to countless patients. We are honored to have Michael Magnani, the President of CLS, joining us today to explore their new thermal therapy system for image-guided focal laser ablation. With a career spanning over two decades in corporate management within the life sciences industry, he brings a wealth of expertise in product development, corporate strategy, business development, and commercialization. He graduated from the unique Biomedical Enterprise Program at the MIT Sloan School of Management and holds a Bachelor of Science in Microbiology from the University of California, San Diego. Join us to learn about the exciting possibilities this transformative new technology holds for the future of prostate cancer management! Disclaimer: The Prostate Health Podcast is for informational purposes only. Nothing in this podcast should be construed as medical advice. By listening to the podcast, no physician-patient relationship has been formed. For more information and counseling, you must contact your personal physician or urologist with questions about your unique situation. Show highlights: Michael discusses what they are doing at CLS
The benefits of offering targeted focal therapy as an alternative treatment for prostate cancer
Michael walks through the device components of the CLS thermal therapy system, explaining how it works in targeting prostate cancer and how it gets deployed within a urological setting
What are the advantages of using targeted focal laser ablation for prostate cancer?
Who would be considered an appropriate candidate for CLS thermal therapy?
Some of the potential risks associated with focal laser ablation treatment
How the CLS mobile services model works for a urologist practice
How can adopting a concierge business model allow urologists to provide early access to some emerging technologies?
What can a patient expect during the procedure and in the recovery phase?
The strides made by CLS in developing its CLS thermal therapy system for image-guided focal laser ablation offers hope for countless patients. The future of prostate cancer management is undoubtedly brighter with innovations like these, and we invite you to tune into future episodes where we will continue to explore the new and transformative possibilities that lie ahead. Thank you for joining us on this remarkable journey of discovery! Links: Follow Dr. Pohlman on Twitter and Instagram - @gpohlmanmd Get your free What To Expect Guide (or find the link on our podcast website) Join our Facebook group Follow Dr. Pohlman on Twitter and Instagram Go to the Prostate Health Academy to sign up. You can access Dr. Pohlman's free mini webinar, where he discusses his top three tips to promote men's prostate health, longevity, and quality of life here. Clinical Laserthermia Systems (CLS)
More from The Prostate Health Podcast
For decades, prostate cancer treatment required critical decision-making based on an imperfect picture of the exact location and extent of the cancer. Artificial intelligence, however, can provide a much clearer, three-dimensional picture of each patient's cancer, helping us match the treatment to the individual. We're delighted to welcome board-certified urologist Dr. Pankaj Jain of Arizona Urology as today's guest. Dr. Jain completed his urology residency at Northwestern University. He is recognized as a leader in minimally invasive surgery and for adopting innovative technologies at the forefront of urologic care. Dr. Jain joins me today to explore how artificial intelligence is changing the way we understand and treat prostate cancer. I'm especially excited to discuss Unfold AI, a revolutionary new tool for planning and guiding prostate cancer treatment. Stay tuned to learn how AI is changing how we understand, plan for, and treat prostate cancer. We're excited to partner with Avenda Health to bring you this episode! Disclaimer: The Prostate Health Podcast is for informational purposes only. Nothing in this podcast should be construed as medical advice. By listening to the podcast, no physician-patient relationship has been formed. For more information and counseling, you must contact your personal physician or urologist with questions about your unique situation. Show Highlights: Dr. Jain explains what Unfold AI is and how it can help with prostate cancer treatment planning
We're grateful to partner with Procept BioRobotics to bring you this episode. Today, we're excited to welcome two special guests to the Prostate Health Podcast. Dr. Gerald Park, a board-certified urologist from Kansas City Urology Care, is a recognized innovator in BPH management and a pioneer in bringing advanced treatment technologies to patients throughout the region. J.D. is a 54-year-old gentleman who has struggled with BPH for many years. Like many men, his symptoms gradually worsened over the years, eventually impacting his bladder and kidney health. J.D.'s longstanding BPH journey brings today's conversation to life. With Dr. Park's guidance, he gained the clarity and confidence he needed to make an informed treatment decision and achieve meaningful relief from his symptoms. Stay tuned as we explore how modern patient-centered BPH consults can help patients better understand their condition, their treatment options, and the outcomes that matter most to them. Disclaimer: The Prostate Health Podcast is for informational purposes only. Nothing in this podcast should be construed as medical advice. By listening to the podcast, no physician-patient relationship has been formed. For more information and counseling, you must contact your personal physician or urologist with questions about your unique situation. Show Highlights: Dr. Park debunks the misconceptions most patients with bothersome urinary symptoms have about an enlarged prostate or BPH.
Artificial intelligence is transforming nearly every aspect of healthcare, but what does that actually mean for men with prostate cancer? Today, we are delighted to welcome Dr. Jason Hafron to discuss the Artera AI Prostate Test and explain how it helps clinicians and patients determine the optimal personalized prostate cancer treatment plan. Dr. Hafron is a board-certified urologist, the Chief Medical Officer and Medical Director of Clinical Research at the Michigan Institute of Urology, and a professor of urology at the William Beaumont School of Medicine at Oakland University in Royal Oak. He is experienced in all areas of urology, has published numerous peer-reviewed journal articles, and has presented his research at national and international scientific meetings. Stay tuned as we take a closer look at the Artera AI Prostate Test and explore how it is helping physicians better predict risk, personalize treatment plans, and give patients greater confidence as they make some of the most important decisions of their lives. We are excited to partner with Artera for this episode of the Prostate Health Podcast. Disclaimer: The Prostate Health Podcast is for informational purposes only. Nothing in this podcast should be construed as medical advice. By listening to the podcast, no physician-patient relationship has been formed. For more information and counseling, you must contact your personal physician or urologist with questions about your unique situation. Show Highlights: Why prostate cancer treatment decisions need to be personalized
We are excited to partner with Richard Wolf Medical Instruments, a company at the forefront of urologic innovation and advanced surgical technology, for this episode of the Prostate Health Podcast. For decades, men with enlarged prostates have had to choose between living with disruptive urinary symptoms and undergoing invasive surgery. Now, holmium laser enucleation of the prostate, or HoLEP, is changing that by offering a minimally invasive treatment with proven long-term results, while new surgical innovations are taking the procedure to the next level. Today's guest is Dr. Austin Slade, a nationally and internationally recognized urologic surgeon and one of the most experienced HoLEP specialists in the United States. Known for his surgical precision, exceptional patient outcomes, and commitment to advancing minimally invasive prostate care, Dr. Slade is sought out by patients and referring physicians from across the United States and around the world for the treatment of enlarged prostate symptoms. Join us as Dr. Slade offers his insights on why the HoLEP procedure has become a leading long-term treatment for BPH and how recent advances in surgical instrumentation are enabling surgeons to deliver even better outcomes for their patients. Disclaimer: The Prostate Health Podcast is for informational purposes only. Nothing in this podcast should be construed as medical advice. By listening to the podcast, no physician-patient relationship has been formed. For more information and counseling, you must contact your personal physician or urologist with questions about your unique situation. Show Highlights: What is BPH, and when should you seek evaluation?
We are thrilled to partner with BioProtect for this episode of the Prostate Health Podcast. Radiation therapy is a highly effective treatment for prostate cancer. Navigating potential side effects, particularly radiation effects on the rectum, is a key challenge when making a decision. Fortunately, a new technology helps reduce the short- and long-term risks associated with treatment. Today, for the first time on the podcast, we're featuring both a urologist and a radiation oncologist to give our listeners a true multidisciplinary perspective on how a biodegradable balloon spacer provides precise, predictable spacing for radiation therapy in prostate cancer. We are delighted to have board-certified urologist Dr. Jeffrey Wolters, MD, and board-certified radiation oncologist Dr. Coyt Rountree, MD, both from Florida Cancer Specialists, joining us today. Dr. Wolters and Dr. Rountree are leading experts in the management of prostate cancer with significant experience using the BioProtect balloon spacer. Stay tuned for more! Disclaimer: The Prostate Health Podcast is for informational purposes only. Nothing in this podcast should be construed as medical advice. By listening to the podcast, no physician-patient relationship has been formed. For more information and counseling, you must contact your personal physician or urologist with questions about your unique situation. Show Highlights: What patients need to know about radiation before starting treatment